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Increased thymidylate synthase protein levels are principally associated
with proliferation but not cell cycle phase in asynchronous human cancer
cells
BC Pestalozzil, CJ McGinn', TJ Kinsella', JC Drake', MC Glennon2, CJ Allegra' and PG
Johnston'
'NCI-Navv Medical Oncology Branch, National Cancer Institute, Bethesda, Marvland 20889-5105 and 2Department ofHuman
Oncology, University of Wisconsin, Madison, Wisconsin 53792, USA.
Sm_nary We have analysed cell cycle variations in thymidylate synthase (TS) protein in asynchronously
growing NC] H630 and HT 29 colon cancer and MCF-7 breast cancer cell lines. Western immunoblot analysis
using the TS 106 monoclonal antibody revealed a 14- to 24-fold variation in TS levels between the peak
exponential and confluent growth phase in the three cell lines. Similar variations in T'S levels and TS activity
were detected using the 5-fluorodeoxyuridine monophosphate and deoxyuridine monophosphate biochemical
assays. The percentage of cells in S-phase, which paralleled changes in TS levels, reached a maximum of
38-60% in asynchronous exponentially growing cells compared with 5-10% in confluent cells. In asyn-
chronous exponential cells, analysis of TS levels in each cell cycle phase using two-parameter flow cytometric
analysis revealed that TS protein levels were 1.3- to 1.5-fold higher in S than in GD'GI phase cells, and 1.5- to
1.8-fold higher in G,/M than GO,/GI cells. Similar differences of 1.1- to 1.5-fold between GO/GI and S-phase
and 1.6- to 1.9-fold between GWGI and G ,,'M-phase were detected by Western immunoblot and biochemical
assays. TS protein was not detectable by Western blot analysis, flow cytometry or biochemical analysis in the
GO,GI population of confluent cells. Twenty-six per cent of cells in this population were Go cells compared
with 2% in exponentially growing cells. In contrast to TS, a 4-fold difference in thymidine kinase ('UK) was
detected between GO,GI and S-phase cells in exponentially growing MCF-7 cells. The level of T'S enzyme is
associated with cellular proliferation and the percentage of cells in S-phase, however, TS protein is not
exclusively associated with S-phase in asynchronously growing cells. The variation in TS levels between
exponentially growing and confluent cell population appears to be due to differences in TS levels between Go
and GI cells.
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Thymidylate synthase (TS; EC 2.1.1.45) catalyses the reduc-
tive methylation of deoxyuridine monophosphate (dUMP) to
deoxythymidine monophosphate (dTMP). This reaction is an
essential step in DNA biosynthesis, since it provides the only
de novo source of thymidylate. TS is also a cnrtical target for
the fluoropyrimidine drugs that are widely used in the treat-
ment of breast cancer, as well as tumours of the gastrointes-
tinal and upper aerodigestive tracts. In tumour cells, 5-
fluorouracil (5-FU) and fluorodeoxyunrdine (FdUrd) are con-
verted to 5-fluorodeoxyuridine monophosphate (FdUMP),
which forms a covalent ternary complex with TS in the
presence of the folate co-factor 5, 10-methylene tetrahyd-
rofolate (5, l0-CH2H4PteGlu).
Previous studies have demonstrated in both mammalian
and yeast systems that TS activity is higher during DNA
replication and decreases when cells are non-dividing (Con-
rad, 1971; Maley and Maley, 1960; Navalgund et al., 1980;
Storms et al., 1984). Other studies have shown that, while
increased TS activity correlates with the DNA synthetic
phase, this increase is not blocked by inhibitors of DNA
synthesis (Jenh et al., 1985). This suggests that, while TS
activity may be associated with proliferation, its regulation
may be independent of DNA synthesis and cell cycle phase.
More recent studies have demonstrated that TS enzyme levels
rise acutely when cells are exposed to cytotoxic agents such
as 5-FU (Chu et al., 1990). Thus, in addition to changes in
TS related to the cell cycle, neoplastic cells may increase TS
levels as a protective mechanism against cytotoxic stress. This
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acute induction of TS protein may represent an important
mechanism in the development of tumour resistance.
Recently, we have developed several monoclonal anti-
bodies to human TS that are highly specific and detect TS in
the cytoplasm of tumour cells and tissue (Johnston et al.,
1991, 1992). These antibodies have facilitated the study of TS
in cell lines and human tissues and have allowed TS to be
measured within individual cells. We have also demonstrated
that increased TS protein levels predict for poor clinical
outcome in patients with rectal cancer (Johnston et al., 1994).
This may be the result of the association of TS protein levels
with cellular proliferation.
The purpose of this study was to analyse cell cycle varia-
tions in TS levels during the various cell cycle phases and
proliferation to determine its association with DNA synthesis
and S-phase in asynchronously growing tumour cells.
Materials and methods
Chemicals
Dextran (clinical grade), 5-FU, acid-washed activated char-
coal, fluorescein isothiocyanate (FITC)-labelled goat anti-
mouse conjugate, propidium iodide, cycloheximide,
thimerosal and non-specific murine ascitic fluid were all pur-
chased from Sigma. (St Louis, MO, USA). [6-3H]5-FdUMP
(specific activity 23 Ci mmol' and [5-3H]dUMP (sp. act. 22
Ci mmol-') were obtained from Moravek Biochemicals
(Brea, CA, USA). The ECL-enhanced chemiluminescence kit
was obtained from Amersham (Buckinghamshire, UK). Nit-
rocellulose membranes were purchased from Schleicher &
Schuell (Keene, NH, USA). The monoclonal antibody to
x-tubulin was obtained from Oncogene Science (Uniondale,
NY, USA). Ki-67 monoclonal antibody was obtained from
Dako (Carpinteria, CA, USA). Goat anti-mouse horseradishThi,IiNa - NWd qd
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peroxidase conjugate, BioRad protein assay, Tween 20 and
SDS were obtained from Bio-Rad Laboratories (Richmond,
CA, USA). Tris and glycine were purchased from Schwarz/
Mann Biotech, ICN Biomedicals (Clveland, OH, USA).
Phosphate-buffered sine (PBS) was obtained from Digene
Diagnostics (Beltvile, MD, USA). Acrylamide was pur-
chased from National Diagnostics (Atlanta, GA, USA).
Ammonium persulphate was bought from BRL Life Tech-
nologicals (Gaithersburg, MD, USA). Camation non-fat
milk: was obtained from Carnation (Los Angeles, CA,
USA).
Cell culture
The characteristics of the human colon cancer cell lines NC
H630 and HT 29 and the human breast cancer cell line
MCF-7 have been previously described (Park et al., 1987;
Soule et al., 1973). All cells were maintained in RPMI-1640
(Gibco, Grand Island, NY) with 10% heat-inactivated fetal
calf serum (FCS) plus 2mM glutamine. For proliferation
assays, cells were seeded on day 0 at a density of2 x 104 cells
cm 2. Doubling times were calculated over the first 72 h of
cell growth using linear regression analysis.
CeUlharvest
Cells were trypsinised, resuspended in RPMI medium con-
taining 10% FCS, and an aliquot was counted using a ZF
Coulter Counter (Coulter Eectronics, Hialeah, FL, USA).
Cells were washed twice in ice-cold PBS and stored as pellets
at -80C. Before analyss, cells were lysed by sonication in
0.1 M potassium dihydrogen phosphate pH 7.4. Sonication of
1 x 106 cells ml-I was performed with four 2-s bursts from a
Vibra cell soniler from Sonics and Materials (Danbury, CT,
USA). The cellular extracts were centrifuged at 5000g for
15min, and the supernatants collected. Protein concentra-
tions were determined using the BioRad protein assay (Brad-
ford, 1976).
Western blot analysis
Equivalent amounts of protein (400 g) from each cellular
lysate were resolved by polyacrylamide gel eectrophoresis
using 12.5% acrylamide, according to the method of Laem-
mli (1970). The gels were electroblotted onto a nitrocellulose
membrane in transfer buffer (48 mM Tris, 39 mM glycine,
0.5 M EDTA in 20% methanol) for 2 h. The nitrocllulose
blots were treated at room temperature with blocking solu-
tion (blotto: 5% Carnation non-fat milk, 10mM Tris, 0.01%
thimerosal) for 45 min. After washing with PSB-Tween (PBS
with 0.1% Tween 20), primary antibody (TS 106, ascitic
fluid, 1:100 in blotto) was added for 90min. After two
washes with PBS-Tween and three washes with blotto,
secondary antibody (goat anti-mouse horseradish peroxidase,
BioRad, 1:1000 in blotto) was used for 60 min. After another
four washes with PBS-Tween, the chemiluminescent subs-
trate (luminol, plus enhancer, according to the ECL method
of Amersham) was applied for I min. Blots were then air
dried, covered by a plastic foil and exposed to film (Kodak,
X-OmatAR) for 5-60s. Densitometry scanning of the film
was performed using a Hewlett-Packard Scan Jet Plus and
analysed using an image analysis softwar program (NIH
IMAGE v.1.40; provided by Wayne Rasband, NIMH, NIH,
Bethesda, MD, USA).
FdUMP binding assay
Equivalent volumes ofcytosolic extracts (50p) were assayed
in duplicate. The assay was performed in a total volume of.
200X 1 conining 75FM 5, 10-CH2H.PtGlu, 3 pmol of
[3H]FdUMP, 100 mM 2-mercaptoethanol and 50mm potas-
sium dihydrogen phosphate pH 7.4 as has been previously
described (Moran et al., 1979; Johnston et al., 1991).
dUMP catalytic activity
Equivalent volumes of cytosolic extracts (50p1l) were assayed
in duplicate. The assay was performed in a final volume of
200MI containing 100 pmol [5-3H]dUMP, 100 mM 2-
mercaptoethanol, 50 mM potassium dihydrogen phosphate
pH 7.2 and 50 il (or 5 p1) of cellular extracts as previously
described (Roberts, 1966).
Thymidine kins assay
Thymidine kinase was assayed as previously described by
Ives et al. (1969). The reaction mixture consisted of 1OmM
ATP, 1OmM magnesium chloride 50 mM Tris-HCI pH 7.5,
15 mM sodium fluoride 0.1ILCi [3HJthymidine (Moravek
20Ci mmol'), 511M unlabelled thymidine, 1-20 1l of cell
lysate in a total volume of 50p1. The reaction was allowed to
proceed for 30min at room temperature and stopped by
boiling for 60 s. The reaction as measured was linear with
time, and the rate was proportional to the lysate volume
used. The assay mixture was spotted onto a 2.5cm DE 81
ion-exchange disc (Whatman). After 10 min the disc was
washed with three changes of distilled water, 30 ml per disc,
and then placed in scintillation vials containing 1 ml of 0.1 M
hydrochloric acid-0.2M potassium chloride, and the vials
were gently shaken for 20min. Scintillation fluid was added
and samples counted in a scintillation counter. The values
were expressed as pmol min-' mg-' cytosol protein.
Cell cycle distribution
One to two million cells were resuspended in 0.7 ml of ice-
cold PBS and fixed by adding 1.3 ml of 95% ethanol with
0.5% Tween 20 drop wise to the cell suspension with gentle
vortex mixing. The cell suspension was kept at 4 C overnight.
Cells were washed once in PBS and resuspended in 0.5 ml of
PBS-TB [PBS with 0.1% (w/v) bovine serum albumin and
0.5% Tween 201 containing I0 tgml-' RNAse and incubated
at 37C for 20 min. Cells were then pelleted and resuspended
in 0.5 ml ofPBS-TB containing 501ig ml-' propidium iodide
(PI). Cell cycle data were acquired using a Becton-Dickinson
FACScan with 15 mW excitation at 488 nM. The PI signal
was assessed through a 650 long-pass filter on FL3. The
software used for acquisition and analysis was the CellFIT
cell cycle analysis program version 2.01.2 from Becton-
Dickinson Immunocytometry Systems (San Jose, CA,
USA).
Two-parameterflow cytometry with TS and PI
Aliquots oftwo million cells were harvested by centrifugation
at 500g, washed and fixed as above. Cells were placed in
blocking buffer BSA-T (3% BSA, 0.2% Tween 20 in PBS) at
4-C for 30min. After pelleting, cells were incubated with
200p1 of the primary antibody (TS 106 monoclonal or non-
speific ascitic fluid as a control at 1:100 dilution in PBS) for
at least 1 hr at 4-C. After one wash cells were incubated with
200 p1l of the secondary antibody: goat anti-mouse immuno-
globulin-fluorescein isothiocyanate (FITC) conjugate diluted
1:50 in PBS-TG [PBS with 0.1% (v/v) goat serum and 0.5%
Tween 20]. After two washes, samples were resuspended in
0.5 ml of PBS-TB containing 50 iLgml1' of PI. The PI signal
was as d as described above. The FITC signal was col-
ected through a 530/30 bandpass filter on FLI. Analysis was
performed with the LYSYS ll software version 1.1 from
Becton-Dickinson. The analysis was restricted to singlets
using pulse area vs pulse width gating of the PI signal. A
DNA histogram was obtained from each sample and boun-
daries were established based on the mean channel of the GI
and G2/M peaks to define Go/GI, S-phase and G2/M regions.
In both the control population (ascitic fluid diluted 1:100 in
PBS) and the population incubated with TS 106, the mean
fluorescent intensity (MFI) of the FITC signal was deter-
mined from each phase ofthe cell cycle. Ratios of relative TSThymidyite syndhase and cellcyde
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staining intensities between different cell cycle phases were
then calculated, after correcting for non-specific staining.
Cell cycle sorting using Hoechst 33342
Unfixed cells were stained with the supervital stain Hoechst
33342 according to the method of Crissman et al. (1990).
Cells in Go GI. S and G,M were then sorted according to
their DNA content. using a Becton-Dickinson FACStar Plus
flow cytometer with 100 mW excitation at 351-465 nm. The
Hoechst 33342 signal was assessed through a 400 long-pass
filter into three distinct populations: GO,/GI phase, S-phase
and GI,M-phase cells. Pellets were stored at -80°C until
assayed for TS protein levels and TS biochemical activity.
Sorted populations were confirmed to contain only Go,,G1, S
or G, M cells by subsequent cell cycle analysis with PI.
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Figre 1 TS levels in asynchronous populations of three human
cancer cell lines. TS levels were measured by three different
methods as a function of time: immunoblot analysis (*),
FdUMP binding assay (0) and dUMP catalytic activity (A).
The three graphs display results for NC] H630 (a), HT 29 (b) and
MCF-7 (c) cells. Cells were plated at 2 x 10' cells cm-2 and
grown for up to 288 h. After harvest. crude cellular extracts were
made by sonication and aliquots were analysed in parallel by
immunoblot. FdUMP binding and dUMP catalytic assays respec-
tively. The results represent the mean ± s.d. of three separate
experiments.
Tw o-parameterflow cs tometrv ith Ki-67 and PI
This assay was based on a previously published method
(Baisch and Gerdes. 1990). After harvest. one million cells
were resuspended in 2 ml of 0.15 M sodium chloride at 4°C.
The suspension was added dropwise to 8 ml of ice-cold pure
acetone while gently shaking. Cells were stored for at least
24 h at - 20°C. After centrifugation and decanting. 0.1%
RNAse in PBS was added and the sample incubated for
20 min at 37°C. After pelleting. 100 gI of Ki-67 antibody
(1: 10 dilution in PBS containing 1% BSA) was added.
Incubation lasted 30 min at room temperature with gentle
shaking. Subsequently. 100 ul of FITC-conjugated goat anti-
mouse antibody (1:40 in PBS-BSA) was added and
incubated for 30 min at room temperature. After washing in
PBS. 0.5 ml of PI (2 gg ml-' in PBS) was added for 20 min in
the dark. Data were acquired and analysed as described
above. The control populations in these experiments were
incubated with non-specific mouse ascitic fluid rather than
the Ki-67 antibody. The baseline fluorescence of the log-
amplified Ki-67 FITC signal was set using the appropriate
negative control for each sample. Peak fluorescence on Fll of
this population was used to determine the upper boundary
for cells considered to be Ki-67 negative.
Results
TS and cell c! cle analysis during asynchronous grow th
NCI H630. HT 29 and MCF-7 cells were seeded at an
equivalent density (10' cells cm-2). The doubling time for
NCI H630 cells was 25 h. for HT 29 cells 22 h and for
MCF-7 cells 19 h. TS levels were measured at various time
points during asynchronous grow%th (hours 0. 24. 48. 72. 96.
120. 144. 168. 192. 240 and 288). Immunoblot analysis
revealed a 14- to 24-fold variation in TS protein levels from
peak exponential growth phase to confluent growth phase in
the three cell lines. TS levels were maximal after 48 h of
growth and reached the lowest level after 120h (Figure 1).
The drop in TS from the maximal to the lowest basal level
occurred over a brief period of time (48 h) between hours 72
and 120. Similar variations in TS protein levels and TS
activity over time were also detected using the FdUMP bin-
ding and the dUMP catalytic assays respectively (Figure 1).
Comparing all three methods. the differences between the
maximum and minimum TS level were 14- to 17-fold in the
H630 colon cancer cell line. 15- to 23-fold in the HT 29 colon
cancer cell line and 19- to 24-fold in the MCF-7 breast
cancer cell line (Table 1). The change in TS levels was
paralleled by similar variations in the distribution of cells
through the cell cycle (Figure 2). The peak percentage of
S-phase cells was reached after 24-48 h of growth and
decreased 6- to 10-fold after 120 h. Thus. increased TS levels
were associated with increased DNA sxnthesis.
TS anal vsis bi cell cycle phase
Two-parameterflow cytometry and cell sorting Exponentially
growing asynchronous NCI H630, HT 29 and MCF-7 cells
were analysed by two-parameter flow cytometry for TS pro-
tein and DNA content. TS was measured as FITC
fluorescence intensity and DNA content as PI fluorescence
Table I TS levels in confluent vs exponentially growing cells
Immunoblot FdLMVP 4ssav d UMP assay
relative densitri (pmolmg- pmolmin-' mg-
Cell line IeariationA Afaximumb I ariationA Afaximum I'ariation'
H630 14-fold 0.675 ± 0.04 17-fold 6.89 ± 0.2 15-fold
HT 29 '3-fold 0.269 ± 0.01 15-fold 4.84 ± 0.3 19-fold
MCF-7 22-fold 0.809 ± 0.02 24-fold 13.7 ± 0.5 19-fold
'Variation between maximum level of mean TS (exponential growth phase) and mean
basal level of TS (plateau phase. hours 120-288). bMaximum level of mean TS measured
during exponential grow%th phase.
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Figwe 2 Cell cycle analysis of asynchronous cell populations as
a function of time in (a) NC] H630, (b) HT 29 and (c) MCF-7
cells. The graph shows the percentage of cells in GO/G, (A), S
(0) and GJM (-) phase. After harvest, 2 million cells were fixed
in ethanol and stained with propidium iodide for cell cycle
analysis by flow cytometry. The results represent the mean ± s.d.
of three separate experiments.
Table n Relative TS level at different cell cycle states measured by
two-parameter flow cytometry
Cell line S vs Go,,G G2/M vs GOGI
NC] H630 1.52 0.20 1.68 ± 0.10
HT 29 1.33 +0.09 1.53 ± 0.06
MCF-7 1.47±0.12 1.82±0.22
TS levels were measured as mean FITC staining intensities in
exponentially growing cells at different cell cycle stages. Relative TS
levels are ratios of the staining intensity of S or G/M phase cells
compared with GnUGI phase. Results are means ± s.d. of three
expenrments.
intensity. Analysis of TS staining intensity by cell cycle phase
is demonstrated in Figure 3 and summarised in Table II. TS
levels in S-phase cells were 1.3-1.5 times higher than in
GO/GI and 1.5-1.8 times higher in G2,IM than in GO/GI
phase.
TS Western immunoblot analysis To evaluate further TS
protein levels during each phase of the cell cycle, we per-
formed Westernim unoblot analysis of cytosolic prepara-
tions from exponentially growing NC] H630, HT 29 and
MCF-7 cells that had been sorted into GD/G1, S and G2/M
phase according to their DNA content. In exponentially
0I a I I A
0 200 400 600 800 1000
PI fluorescence intensity
(arbitrary units)
Fugwe 3 Two-parameter flow cytometry of TS (y-axis) and
DNA (x-axis) on exponentially growing cells (48 h). TS staining
was performed with TS 106 as the primary antibody (1:100 in
PBS) and a goat anti-mouse FITC conjugate as the secondary
antibody (1:50 in PBS). Control populations were treated with
non-specific ascitic fluid (1:100 in PBS) and the same FITC
conjugate. DNA staining was performed with propidium iodide.
The staining of NCI H630 cells is shown in a, HT 29 cells in b
and MCF-7 cells in c. Each panel is a representative experiment
that was performed 2-4 times.
growing NCO H630 cells, densitometric scanning revealed a
1.5 ± 0.2-fold increase in TS from GO/GI to G2/M (Figure 4,
lanes 1-3). In HT 29 and MCF-7 breast cells, TS increased
1.3 + 0.1-fold and 1.2 ± 0.3-fold between GO/GI and S-phase
and 1.8 ± 0.2-fold and 1.6 ± 0.4-fold between GO/GI and GJ
M phase respectively.
TS biochemical analysis We also measured TS catalytic
activity and TS FdUMP binding activity in GO/GI and S-
phase cells sorted from exponentially growing NCO H630 and
MCF-7 cells. In NCI H630 cells, a 1.1-fold increase in TS
catalytic function and FdUMP binding activity were also
noted between S and GO/GI phase in MCF-7 cells (Table III).
Thus, using biochemical analysis, two-parameter flow
cytometry and Western immunoblot analysis, TS protein in-
creased by approximately 1.1- to 1.5-fold between GO/GI and
G2JM phase in asynchronous, actively proliferating cell
populations.
Measurement of thymidine kinase activity TK activity was
measured in exponentially growing MCF-7 cells that had
been sorted into GO/GI and S-phases to determine if cell cycle
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Fugwe 4 TS immunoblot analysis in sorted cell populations.
NCI H630 ceUls were stained supravitally with Hoechst 33342 and
sorted by fluorescence-activated cell sorter according to their
DNA content. (a) TS analysis using the TS 106 antibody of cells
in exponential growth phase (48 h) sorted into GCJ/G (lane 1), S
(lane 2) and GJM phase (lane 3) populations; cells after full
confluence (6 days; lane 4) or serum starvation (3 days; lane 5)
sorted for GO/GI cels. Tbere were not enough cells in S and
GJM phase in these last two populations to permit a separate TS
analysis. (b) A control experiment using a monoclonal antibody
to tubulin on the same immunoblot as shown in a.
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Fugwe 5 Ki-67 staining of exponential versus confluent NCI
H630 cells. In the confluent population (6 days after plating) the
Ki-67 staining shows a two-peak configuration, being absent in
part of the cells (26%) and low in the remainder of the cells (left
tall peak). By contrast, in the exponentially growing population
(48 h) 98% of cells stain positive for Ki-67 and staining intensity
is 4-fold higher (right broad tall peak).
variations in TK could be detected in these asynchronous
cells. In contrast to TS activity, TK activity was 4-fold higher
in S-phase than in GO/GI phase cells (Table IV).
TS analysis in sorted confluent cells We analysed TS in
sorted GD/GI, S and G2/M populations from NO H630, HT
29 and MCF-7 cells grown to full confluence and from NC
H630, HT 29 and MCF-7 cells grown in 0.5% bovine calf
Table 111 TS level at different cell cycle phases measured by
biochemical FdUMP and dUMP assays
FdUMP binding dUMP catalytic
(pmolmg 1) (pmolmini mg-)
Cell line GOIG, phase S-phase GO/G, S-phase
NC] H630 0.5 0.2 0.6 0.2 10.7± 1.2 12.3±6.3
MCF-7 0.7 0.1 0.9 0.2 19.7 1.1 24.5 2.2
TS levels were measured using the FdUMP and dUMP
biochemical assays in GO/GI and S-cells sorted from exponentially
growing NC] H630 and MCF-7 cells. The results are means ± s.d. of
two experiments.
Table IV The level of thymidine kinase measured at different cell
cycle phases in MCF-7 cells
TK activity
Cell ccle phase (pmolmin-, mg-
GOIG, 61 4
S 239 22
TK levels were measured in GD,G, and S-cells sorted from
exponentially growing MCF-7 cells as described in Materials and
methods. The results are the mean ± s.d. of two experiments.
serum for 120 h. TS protein was not detectable (lower limit
of detection 1 fmol) in the GO/GI populations from confluent
cells using immunoblot, immunofluorescent scanning or
biochemical assays. There were insufficient S and G2/M phase
cells in the confluent cell population to permit TS analysis
(Figure 4, lanes 4 and 5).
Separating GOfrom G, phase using Ki-67
Ki-67 is a nuclear antigen expressed in proliferating cells (G1,
S and G2/M phases) but not in quiescent cells (Go) (Gerdes et
al., 1984; Baisch and Gerdes, 1987). Ki-67 analysis of NC]
H630 cells demonstrated that 98% ± 0.32% of cells in
exponential growth stained highly positive (mean Ki-67
fluorescence 120 ± 40) (Figure 5). By comparison, 26% ±7%
of confluent NCO H630 cells were negative for Ki-67 (Go
population). The remainder had a very low Ki-67 staining
intensity (mean Ki-67 fluorescence intensity 30± 6) (Figure
5). The decrease in TS levels observed when cells reach
confluence was associated with a 13-fold increase in Go
cells.
Dicsion
In this report, we have described an analysis of TS protein
levels and TS activity in cells during proliferation and during
the different phases of the cell cycle using the monoclonal
antibody TS 106 and standard biochemical assays. We have
demonstrated that TS protein and TS activity levels are
higher in proliferating than in non-proliferating cells and
vary 14- to 24-fold between exponential and confluent cell
populations. Maximum TS expression corresponds to the
period when the highest percentage of cells are in S-phase
(38-60%), while lowest TS protein levels are associated with
the least percentage of cells in S-phase (5-10%). Thus, in-
creased TS protein levels and TS activity are associated with
cellular proliferation and DNA synthesis. This is in agree-
ment with previous studies that have demonstrated a 17-fold
variation in TS between resting and exponentially growing
cells (Conrad, 1971; Conrad and Ruddle, 1972).
In contrast, two-parameter flow cytometry and immunob-
lot analysis of sorted cell populations demonstrates that TS is
present in actively proliferating asynchronous cells in all
(GO/GI, S and G2/M) phases of the cell cycle. In this popula-
tion, S and G2/M cells have 1.1- to 1.8-fold more TS than
cells in GO/GI. Conversely, in a confluent cell population, the
TS level of the GO/GI population in NCI H630 cells is
undetectable. The GO/GI population in proliferating NCO
H630 cells is composed entirely of GI cells (98%), while in
confluent nonproliferating NCI H630 cells the GO/GI popula-
1155Thymddylate synTbase and cellcyde
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tion is composed of 13-fold more Go cells. In contrast to TS.
TK is more tightly associated with S-phase. Exponentially
growing MCF-7 S-phase cells have approximately 3- to 4-
fold more TK activity than Go GI cells. Thus. in asvn-
chronously growing human cancer cells. TK but not TS
appears to be closely linked with cell cycle phase.
Previous studies have demonstrated an association between
S-phase and TS protein and have suggested that TS is an
S-phase-specific enzyme (Conrad. 1971: Conrad and Ruddle.
1972). To demonstrate a specific relationship between TS and
S-phase. it is necessary to show an oscillatory pattern of TS
through the cell cycle including a decrease of TS at the end
of S-phase. To accomplish this. investigators have used
chemical synchronisation of cells and sorting of cells into
subpopulations. In studies by Conrad using colcemid syn-
chronisation and the dUMP catalytic assay. a 1.8-fold in-
crease in TS was noted between GI and S phase (Conrad.
1971). Using elutnration of L1210 mouse leukaemia cells.
Cadman and Heimer (1986) have published results on the
relation between TS levels and cell cycle phases. The
differences in TS measured between early (ennrched for G1
phase cells) and late (enriched for G. M phase cells) elutria-
tion fractions were 1.7-fold at replating. 1.2-fold during
exponential growth and 1.5-fold in plateau phase. The levels
of TS in the mid-fractions (enriched for S-phase cells) were
less than the levels in the later (G. M) elutriation fractions.
The investigators suggested that the real differences in TS
between the phases could be underestimated. since the elu-
triation procedure resulted in imperfect cell cycle phase
separation. Our two-parameter flow. Western immunoblot
and biochemical analysis of TS found similar differences
between Go GI and S or GI M phases. and suggests that the
data of Cadman and Heimer (1980) demonstrating a lack of
association between cell cycle and TS levels were real and not
an artifact of imperfect separation of cell phases.
Other investigators have used isoleucine deprivation or
hydroxyurea to synchronise cells, including L1210 mouse
leukaemia cells (Rode et al., 1978) and Chinese hamster
embryo fibroblasts (Reddy. 1982). In those studies cultures
were followed for 12 h after release from these inhibitors.
Using an in situ tritium-release assay. those investigators
found an immediate rise of more than 12-fold (Rode et al..
1978) and 8-fold (Reddy. 1982) in TS activity within 1 h after
release from synchrony. A 4-fold (Rode et al.. 1978) and
10-fold (Reddy. 1982) drop in TS activity was noted at the
end of S-phase 6-8 h later. These studies failed to demon-
strate any variation in TS levels in cellular extracts using the
radiolabelled FdUMP binding assay during the period of
time assayed (Rode et al.. 1978: Reddy. 1982). Xu and
Plunkett (1993) have recently demonstrated that the in situ
radiolabelled dUMP assay is subject to changes in apparent
TS activity resulting from variations in dUMP activity by
TK. Thus. differences between the in situ dUMP and
radiolabelled FdUMP binding TS assays may be the result of
an association of TK rather than TS wvith cell cycle
phase.
Keyomarsi et al. (1991. 1993) synchronised MCF-7 cells
using lovostatin and demonstrated large TS protein oscilla-
tions (10- to 20-fold) with cell cycle phase after release from
synchrony using the FdUMP binding assay. This study sug-
gested that in synchronised cells there is a specific association
of TS with S-phase. since TS not only increases with entry
into S-phase. but also decreases significantly when cells exit
S-phase. The variations in TS noted in this study are in
contrast with our data. but may be the result of the method
of synchronisation using lovostatin.
We have previously reported that the TS protein half-life is
26 h in the NCI H630 cells (Chu et al.. 1993). This is consis-
tent with our data showing the persistence of TS throughout
each cell cycle phase in asynchronously proliferating cells. In
cells that are actively cycling. TS protein persists from one
cell to the next. A major decrease in TS protein levels occurs
only when a cell enters a resting phase and cell cycling is
discontinued. Thus. chemotherapeutic agents that bind to TS
inhibiting conversion of dUMP to dTMP would be expected
to have most activity in proliferating cells (G. S and G. M).
in which the activity of TS protein is important for continued
cellular proliferation.
In summarv. we have shown that TS varies 14- to 24-fold
between exponentiall) proliferating and confluent (quiescent)
human cancer cells. TS is present in Go G,. S and G, M in
proliferating human cancer cells and is not detectable in
Go G, populations separated from confluent cells owing to
the presence of increased numbers of Go cells. In exponen-
tially growing asynchronous cells. the variations in TS
between different cell cycle phases are less than 2-fold. In
asynchronously growing tumour cells. TS protein levels are
directly associated with cellular proliferation and, therefore.
the percentage of cells in S-phase, but large increases in TS
protein levels are not detected in the S-phase population of
asynchronously growing cells.
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